Abstract-based review · 2024
Green-lipped mussel extract and activity in working farm dogs
Some accelerometer measures changed, while the 75th-percentile activity measure did not.
Review scope
Abstract-based review. Full methods, complete statistical results and product equivalence have not been appraised. This is research context, not an individual feeding or treatment recommendation.
Study question and design
32 enrolled working farm dogs with musculoskeletal abnormalities; 27 analysed. Blinded placebo crossover: 180 or 220 mg full-fat extract daily for eight weeks per period, with four-week washout.
Main findings
Some accelerometer measures changed, while the 75th-percentile activity measure did not.
Limitations and applicability
Pilot data, incomplete participation and uncontrolled work activity limit interpretation. The preparation was a particular extract; this is not proof of pain relief from all mussel ingredients.
Ingredients investigated
Direct ingredient investigations
Green-lipped mussel
Direct · dog. Working farm dogs with musculoskeletal abnormalities; 32 enrolled and 27 included in analysis.
Tested form: Full-fat green-lipped mussel extract. Dose: 180 mg/day (Daily oral supplementation; dose subgroup allocation not established in reviewed abstract). Duration: 8 weeks per treatment period with a 4-week washout in a blinded placebo crossover trial. Comparator: Placebo in the crossover trial.
Measured finding: Some peak-activity and interquartile-range measures changed; the 75th-percentile activity measure did not change. The abstract does not isolate every outcome by daily-dose subgroup.
Limitations: Small analysed sample; working dogs with musculoskeletal findings; specific full-fat extract. Activity measures are not interchangeable with demonstrated clinical pain relief.
Green-lipped mussel
Direct · dog. Working farm dogs with musculoskeletal abnormalities; 32 enrolled and 27 included in analysis.
Tested form: Full-fat green-lipped mussel extract. Dose: 220 mg/day (Daily oral supplementation; dose subgroup allocation not established in reviewed abstract). Duration: 8 weeks per treatment period with a 4-week washout in a blinded placebo crossover trial. Comparator: Placebo in the crossover trial.
Measured finding: Some peak-activity and interquartile-range measures changed; the 75th-percentile activity measure did not change. The abstract does not isolate every outcome by daily-dose subgroup.
Limitations: Small analysed sample; working dogs with musculoskeletal findings; specific full-fat extract. Activity measures are not interchangeable with demonstrated clinical pain relief.
Evidence.pet interpretation
Apply this result only within its species, preparation and study conditions. An ingredient listing alone does not establish that a commercial product reproduces the tested intervention.
Funding and conflicts
Not established from the reviewed abstract.
Ingredient references
These are research references. The tested form, dose and formulation must be matched before using a result to support a product claim.
Source
Cave N; Bolton S; Cogger N. A pilot study to detect the effects of a green-lipped mussel (Perna canaliculus) nutraceutical on working farm dogs with musculoskeletal abnormalities using accelerometry. New Zealand Veterinary Journal. 2024. DOI: 10.1080/00480169.2024.2379966.
Primary source record (PMID 39112015) · Publisher DOI
Reviewed 2 October 2026 · Next review 2 January 2027.